Guideline-aligned
Every recommendation maps to the NCSP HPV Primary pathway — Figures 1–10 and Table 1 — inside a versioned, test-covered decision engine.
CerviGrade by Privexa helps hospital screening and colposcopy teams turn referral and lab data into provisional, guideline-aligned recommendations — each one reviewer-gated, auditable, and mapped to the NCSP HPV Primary pathway. Decision support designed for clinicians, not autonomous care.
Provisional · reviewer-gated
Flags bad data first
Outcomes made visible
Every result traceable
The hard part of screening at scale isn't speed — it's confidence. Every surface in the platform is designed so a clinician can trust, check, and stand behind the output.
Every recommendation maps to the NCSP HPV Primary pathway — Figures 1–10 and Table 1 — inside a versioned, test-covered decision engine.
Outputs are provisional. A clinician confirms before any action — the platform never acts on its own.
Outcomes are disaggregated by ethnicity in NZ Level-1 priority order, so inequities are visible — not buried in an average.
Each result carries its source, mapping and engine version, with a full step-by-step decision trace.
A single governed pipeline. The data source can change — the validation, decision engine and audit stay exactly the same.
CSV, Excel or JSON today; HL7 v2 / FHIR R4 adapters defined for later.
NHI, enum and consistency checks with clear, fix-it guidance per row.
The shared engine produces a provisional, guideline-aligned recommendation.
A clinician reviews and confirms before anything is actioned.
Every case stays traceable, with full source and engine metadata.
Batch and manual, validation and equity, integration and audit — all sharing the same decision engine and the same safety guarantees.
Pull many cases at once into provisional recommendations, prioritised for the reviewer.
Step a single case through the guideline pathway, question by question.
NHI, enum and cross-field consistency checks, with suggested fixes before processing.
Outcomes disaggregated by ethnicity in NZ Level-1 priority order.
HL7 v2, FHIR R4, PMS and Health NZ — server-side, governed, mapped to one data contract.
Source-to-decision trace and a per-import audit trail on every result.
The same properties a Quality & Safety Officer would ask for are built in — and visible — rather than promised.
Provisional outputs; clinician confirmation required before any action.
Credentials are server-side only. No secrets are exposed in the frontend.
Mapped to the NCSP HPV Primary pathway; versioned and test-covered.
Source type, system, file, row, mapping and engine version on every result.
Adapter pattern defined for HL7 / FHIR / PMS / Health NZ; activation is governed.
A prototype undergoing clinical validation — not a certified medical device.
A serious screening programme is a team sport. CerviGrade gives each role what they need to say yes.
Confidence that recommendations are guideline-aligned and reviewer-gated.
A clear, prioritised Review Queue with provisional recommendations for clinician confirmation.
An adapter architecture with server-side credentials and one clean data contract.
Full source-to-decision traceability and a per-import audit trail.
Outcomes disaggregated by ethnicity, visible from day one.
Start using CerviGrade today. Explore the guided pathway, upload your data, or review sample results to see how it works.